Every certificate of analysis we publish ends on the same row, and it is the shortest one in the panel: Residual Solvents · Meets USP <467> · GC per USP <467> · Conforms. A chapter number and one word. No measured value.
This piece takes the last row of the panel, the line most often read as if it were blank. It is not blank. It reports something that is not a number.
What a residual solvent is
USP General Chapter <467> defines residual solvents as organic volatile chemicals used or produced in the manufacture of drug substances and excipients, and not completely removed by practical manufacturing techniques.
So a residual solvent is not a contaminant that arrived by accident — it is a deliberate part of the process that did not entirely leave. Fmoc solid-phase peptide synthesis runs on polar aprotic solvents (N,N-dimethylformamide and N-methylpyrrolidone principally, with dichloromethane); reversed-phase purification runs on acetonitrile and water. That describes the synthetic peptides in our catalog, and not the recombinant protein among them, which is not made that way. The row answers one question: how much stayed, against a published ceiling.
Three classes, and a fourth table nobody quotes
<467> sorts solvents by risk assessment, not by chemistry.
Class 1 — to be avoided. Carcinogens and environmental hazards. Five entries, each with its own limit: benzene 2 ppm, carbon tetrachloride 4, 1,2-dichloroethane 5, 1,1-dichloroethene 8, 1,1,1-trichloroethane 1500.
Class 2 — to be limited. Each carries a permitted daily exposure in mg/day and a limit in ppm: acetonitrile 410, N,N-dimethylformamide 880, dichloromethane 600, N-methylpyrrolidone 530, methanol 3000, toluene 890.
Class 3 — low toxic potential. Ethanol, acetone, dimethyl sulfoxide, ethyl ether, heptane and others, limited to not more than 50 mg per day — 5000 ppm, or 0.5%.
Then there is Table 4: "Solvents for which no adequate toxicological data was found." Ten entries, no class and no PDE. Trifluoroacetic acid is one of them. That is why TFA appears on our certificates as its own row — specified at NMT 0.10%, measured by HPLC — instead of being folded into the <467> line. Reporting it there would measure it against a limit the chapter does not contain.
Why the result is a word and not a number
<467> gives three procedures, and they are a cascade, not a menu.
Procedure A is the screen: static headspace gas chromatography with flame-ionization detection on a G43-phase column, the test solution run against Class 1 and Class 2 reference standards. If no peak in the test solution reaches a corresponding peak in a standard, the article meets the requirements and the work stops there.
Procedure B runs only if A found something, repeating the separation on a different stationary phase (G16) to verify the identity of the suspect peak. Procedure C runs only if B confirms it, and is the quantitative step, by standard addition — the one that produces a figure in ppm.
So "Conforms" is not a laboratory declining to report a number. It is the documented outcome of a limit test in which nothing crossed the threshold that would have caused a number to exist. A certificate printing "0 ppm" here would be the more suspicious document.
What the row does not tell you
Which solvents were in scope. The chapter says it is only necessary to test for residual solvents used or produced in the manufacture or purification processes, and that its own tables are not exhaustive. The panel is scoped by the manufacturer's knowledge of its own process, and the certificate does not print that scope. "Conforms" is conformance to whatever was looked for.
That everything relevant is detectable this way. <467> carries its own note that four Class 2 solvents are not readily detected under the headspace conditions it describes: formamide, 2-ethoxyethanol, N-methylpyrrolidone and sulfolane, each needing a separate validated procedure. NMP is one of the two workhorse solvents of Fmoc synthesis. Piperidine, the standard Fmoc-deprotection base, does not appear anywhere in the chapter's list.
What the ppm ceilings were derived from. The Option 1 limits are not measured properties of a powder. They are computed from a permitted daily exposure divided by an assumed 10 g drug-product weight — a pharmaceutical exposure model belonging to the standard, not to research material. It is a compendial reference point, and reading it as anything else is reading it wrong.
Whether the vial holds the right molecule. It does not, and neither does any other row on our certificates. There is no identity test on them — no mass spectrometry, no UV-Vis. This row describes what came along from the process; it says nothing about what the main component is.
One more line, below the panel
The certificates published at www.primesciencesupply.com/certificates carry a sentence under the table: "Testing was performed in accordance with internal analytical methods and applicable pharmacopeial standards where appropriate." Worth reading slowly — it is the sentence that scopes everything above it.
What to ask any supplier, including us
- Which solvents were included in the screen, and on what basis?
- Was any peak escalated to Procedure B or C — and if so, what was the quantified result?
- Is N-methylpyrrolidone covered, and by which procedure?
- Which laboratory ran the GC, and is the document tied to the lot I will receive?
On our own certificates the answer is that the document names the manufacturer and the analyst, and does not name a testing laboratory.
Where our catalog sits
Every item we list carries a ≥98% purity specification by HPLC-UV. Certificate availability and level of detail vary by product and by lot, and the product page states which is which.
To see the format of the panel described above: view published certificates · or start from a catalog reference, the synthetic tetrapeptide Ala-Glu-Asp-Gly: Epithalon (50 mg). Questions about a specific document go to [email protected].
Research Use Only. Not for human or veterinary use. These products are not drugs and have not been approved by the FDA for any purpose. These statements have not been evaluated by the FDA. Prime Science Supply does not provide guidance on preparation, administration, or dosage.